Table 2.
Etiology | Cases (n) |
Chronic hepatitis B | 37 |
Primary sclerosing cholangitis | 36 |
Chronic hepatitis C | 33 |
Chronic hepatitis and hepatocellular carcinoma | 24 |
Primary biliary cirrhosis | 18 |
Cryptogenic liver disease | 18 |
Cystic liver degeneration | 12 |
Autoimmune hepatitis | 12 |
Budd-Chiari syndrome | 12 |
Alcoholic cirrhosis | 10 |
Primary hepatocellular carcinoma | 8 |
Wilson’s disease | 8 |
Others1 | 32 |
Includes: Oxalosis n = 1 (0.4%), acute hepatitis A, n = 1 (0.4%), CMV infection, n = 1 (0.4%), veno occlusive disease, n = 1 (0.4%), Halothane induced hepatic failure, n = 1 (0.4%), cystic fibrosis, n = 1 (0.4%), tyrosinemia, n = 1 (0.4%), amyloidosis, n = 2 (0.8%), hemochromatosis, n = 2 (0.8%), toxic liver failure, n = 2 (0.8%), secondary sclerosing cholangitis, n = 3 (1.2%), alpha 1 antitrypsin deficiency, n = 3 (1.2%), Caroli’s syndrome, n = 3 (1.2%), adenomatosis of the liver, n = 3 (1.2%), carcinoid disease, n = 3 (1.2%), biliary atresia, n = 4 (1.5%).